Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

Journal of Clinical Oncology, Vol 22, No 5 (March 1), 2004: pp. 953-954
© 2004 American Society of Clinical Oncology.
DOI: 10.1200/JCO.2004.03.198

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ascani, S.
Right arrow Articles by Pileri, S. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ascani, S.
Right arrow Articles by Pileri, S. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

DIAGNOSIS IN ONCOLOGY

Difficult Diagnostic and Therapeutic Cases

CASE 1. True Thymic Hyperplasia in a Patient Treated for T-Cell Lymphoma

Stefano Ascani, Philip Went, Anna Marina Liberati, Pier Paolo Piccaluga, Pier Luigi Zinzani, Stefano A. Pileri

Unit of Hematopathology, Institute of Hematology and Clinical Oncology L. & A. Seràgnoli, Bologna University, St Orsola Hospital, Bologna; Institute of Hematology, Perugia University, Perugia, Italy; and Institute of Pathology, Basel University, Basel, Switzerland

A 24-year-old woman presented with rapidly enlarging supraclavicular lymphadenopathy. Biopsy showed complete effacement of the lymph node by a neoplastic population morphologically consistent with lymphoma/leukemia of precursor T-lymphocytes (so-called T-cell lymphoblastic lymphoma/leukemia). The phenotypic profile was as follows: CD34+, TdT+, CD3+, CD1a-, CD4-, CD8-, and Ki-67/MIB-1 95%. No involvement of the bone marrow and peripheral blood was found. She underwent chemotherapy according to the L2 protocol, followed by autologous bone marrow transplantation, which produced complete remission. Six months later, a follow-up computed tomography scan displayed a newly developed mass in the anterior-superior mediastinum that was regarded as suspicious for disease relapse (Fig 1). Given that no other signs and symptoms of malignant lymphoma were present, the mediastinal tumor was surgically removed. On gross examination, it was an encapsulated bilobate mass that measured 11 x 8 x 3.5 cm and weighed 180 g. At light microscopy, the mass consisted of normal thymic tissue with typical lobular architecture, Hassall's corpuscles, and well-defined cortical and medullary compartments (Fig 2, low power with cortex on left and medulla with Hassall's corpuscles on right; Fig 3, high power, with cortical thymocytes and admixed macrophages and epithelial cells). Immunohistochemistry on paraffin sections were carried out by the alkaline phosphatase-antialkaline phosphatase complexes technique [1] with application of specific antibodies against cytokeratins, CD1a, CD2, CD3, CD4, CD8, CD20, CD30, Bcl-2 oncogene product, Bcl-6 protein, TdT, Oct-1, Oct-2, BOB.1, and Ki-67, which showed the expected positivities both in the cortex and medulla [2,3] for true thymic hyperplasia (TTH). Most, if not all, cortical thymocytes did express the proliferation-associated nuclear antigen Ki-67. Interestingly, no lymphoid follicles were observed, in contrast to the thymic lymphoid hyperplasia occurring in patients with myasthenia gravis and other autoimmune disorders [4]. Twenty-eight months after the onset of disease, the patient died of acute respiratory failure as a result of Cytomegalovirus pneumonitis. Unfortunately, the permission for autopsy was denied.



View larger version (55K):
[in this window]
[in a new window]
 
Fig 1.
 


View larger version (163K):
[in this window]
[in a new window]
 
Fig 2.
 


View larger version (153K):
[in this window]
[in a new window]
 
Fig 3.
 
TTH is a rare condition, consisting of enlargement of the thymus gland beyond the upper limits for the corresponding age. It can be related to "stressing" events, such as surgery [5], thermal burns [6], chemotherapy [7], and hyperthyroidism [8,9], or can represent an idiopathic condition [10]. In particular, it has been regarded as a rebound immunologic phenomenon [11], usually regressing in a few months either spontaneously or after steroid therapy.

Based on the present case, one should be aware that in patients with a previous history of T-cell lymphoblastic lymphoma/leukemia or other malignancy, a newly developing mediastinal mass does not always herald a disease relapse with TTH belonging to the spectrum of possible underlying conditions. Notably, under these circumstances, the positron emission tomography scan is of no diagnostic value, since both TTH and T-cell lymphoblastic lymphoma/leukemia consist of highly proliferating cells that avidly uptake 2-deoxy-2 fluoro-D-glucose. In order to achieve the correct diagnosis and to avoid the risk of inappropriate therapeutic decisions (including chemotherapy and total thymectomy), a biopsy is warranted, which should be as large as to allow the identification of the normal thymic structure in case of TTH versus organ infiltration with destruction of the epithelial network in T-cell lymphoblastic lymphoma/leukemia.

Authors' Disclosures of Potential Conflicts of Interest

The authors indicated no potential conflicts of interest.

REFERENCES

1. Cordell JL, Falini B, Erber WN, et al: Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 32:219–229, 1984[Abstract]

2. Hyjek E, Chadburn A, Liu YF, et al: BCL-6 protein is expressed in precursor T-cell lymphoblastic lymphoma and in prenatal and postnatal thymus. Blood 97:270–276, 2001[Abstract/Free Full Text]

3. Marafioti T, Ascani S, Pulford K, et al: Expression of B-lymphocyte-associated transcription factors in human T-cell neoplasms. Am J Pathol 162:861–871, 2003[Abstract/Free Full Text]

4. Pirronti T, Rinaldi P, Batocchi AP, et al: Thymic lesions and myasthenia gravis. Diagnosis based on mediastinal imaging and pathological findings. Acta Radiol 43:380–384, 2002[CrossRef][Medline]

5. Rizk G, Cueto L, Amplatz K: Rebound enlargement of the thymus after successful corrective surgery for transposition of the great vessels. Am J Roentgenol Radium Ther Nucl Med 116:528–530, 1972[Medline]

6. Lee Y, Moallem S, Clauss RH: Massive hyperplastic thymus in a 22 month old infant. Ann Thorac Surg 27:356–358, 1979[Abstract]

7. Mishra SK, Melinkeri SR, Dabadghoo S: Benign thymic hyperplasia after chemotherapy for acute myeloid leukemia. Eur J Haematol 67:252–254, 2001[CrossRef][Medline]

8. Budavari AI, Whitaker MD, Helmers RA: Thymic hyperplasia presenting as anterior mass in 2 patients with Graves disease. Mayo Clin Proc 77:495–499, 2002[Abstract/Free Full Text]

9. Inoue K, Sugio K, Inoue T, et al: Hyperplasia of the thymic gland in a patient with Graves' disease. Ann Thorac Cardiovasc Surg 6:397–400, 2000[Medline]

10. Woywodt A, Verhaart S, Kiss A: Massive true thymic hyperplasia. Eur J Pediatr Surg 9:331–333, 1999[Medline]

11. Suster S, Rosai J: Thymus, in Sternberg SS (ed): Histology for pathologists. New York, Raven Press, 1992, pp 261–277


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Eur J EndocrinolHome page
M. B. C C. Neto, M. C. Machado, F. Mesquita, N. R. de Castro Musolino, A. C. Toscanini, G. Ochman, V. A. S Cescato, R. Marino Jr, and M. J. Teixeira
Thymus hyperplasia after resolution of hypercortisolism in ACTH-dependent Cushing's syndrome: the importance of thymic vein catheterization.
Eur. J. Endocrinol., June 1, 2006; 154(6): 807 - 811.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ascani, S.
Right arrow Articles by Pileri, S. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ascani, S.
Right arrow Articles by Pileri, S. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 2004 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online